KLOW 80MG

KLOW (Kynurenic Acid) – 80MG

KLOW (kynurenic acid) is a naturally occurring tricyclic indole compound derived from the amino acid tryptophan. In the context of experimental research, it has been explored for its potential neuroprotective and neuromodulatory effects in preclinical models. The 80mg formulation is intended for use in academic, pharmaceutical, or advanced research settings where the biochemical properties of kynurenic acid are investigated under controlled laboratory conditions.

Kynurenic acid plays a significant role in the kynurenine pathway, a metabolic route that processes tryptophan and produces a range of neuroactive metabolites. Its primary role includes acting as an endogenous antagonist of glutamate receptors, which may contribute to neuroprotection, modulation of excitotoxicity, and influence on cognitive functions. Due to its biochemical activity, KLOW is often utilized in studies examining neuroinflammation, neurodegenerative diseases, and psychiatric research within an experimental framework.

Research Overview

The investigation of kynurenic acid as a research compound has centered on its pharmacological effects, particularly in relation to glutamate receptor modulation. Preclinical studies have demonstrated its potential in mitigating neuronal damage associated with conditions such as stroke, epilepsy, and traumatic brain injury. Additionally, its influence on neurotransmitter balance and neuroprotective mechanisms has prompted interest in its role in aging research and neurodegenerative disease modeling. Given its biochemical profile, KLOW is also studied in the context of psychiatric research, where its effects on mood and cognitive function are explored under controlled experimental conditions.

Key Research Focus Areas

• Glutamate receptor antagonism and neuroprotection
• Neuroinflammation modulation in preclinical models
• Investigation of kynurenine pathway metabolism
• Neurodegenerative disease modeling (e.g., Alzheimer’s, Parkinson’s)
• Psychiatric and cognitive research (e.g., mood regulation, anxiety)
• Excitotoxicity and neuronal damage mitigation
• Biochemical characterization of endogenous neuroactive metabolites

This research compound is intended for use in academic, pharmaceutical, or advanced research laboratories where the biochemical and pharmacological properties of kynurenic acid are being studied in vitro, in vivo, or in animal models. Always adhere to institutional guidelines, regulatory requirements, and ethical standards pertaining to research materials.

For research use only. Not for human or animal consumption.